1. Home
  2. LGND

LGND

Ligand Pharmaceuticals Incorporated

Logo Ligand Pharmaceuticals Incorporated

Health Care

Biotechnology: Pharmaceutical Preparations

Nasdaq

as 04-16-2024 4:00pm EST

$
-
-
.
-
-
+$
-
.
-
-
+
-
.
-
-
%

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Founded: 1987 Country:
United States
United States
Employees: N/A City: SAN DIEGO
Market Cap: 1.4B IPO Year: 1992
Target Price: $116.33 AVG Volume (30 days): 166.5K
Analyst Decision: Strong Buy Number of Analysts: 3
Dividend Yield: N/A Dividend Payout Frequency: N/A
EPS: 3.03 EPS Growth: N/A
52 Week Low/High: $49.24 - $94.57 Next Earning Date: 05-02-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): 16.74%

Share on Social Networks: